Largest biotech by net assets

Shareholders' equity at the end of the latest fiscal year: what the company owns less what it owes. A negative figure means it owes more than it owns.

Gilead Sciences leads the 24 biotech ranked by net assets, at THB 770.3B, ahead of BioNTech (THB 723.7B) and Biogen (THB 619.5B). Figures as of 18 Nov 2026, 13:49 UTC, from Yahoo Finance quotes.

Key facts

Companies ranked
24
First
Gilead SciencesTHB 770.3B
Median
THB 68.3B
Combined market value
THB 28.81T
Countries
5

Market values as of .

Largest biotech by net assets
#CompanyNet assets ↓Market capPriceToday1 yearPrice, 30 daysCountry
1Gilead SciencesGILD · Health CareTHB 770.3BTHB 7.17TTHB 5,776.92 1.60% up 33% up United States
2BioNTechBNTX · Health CareTHB 723.7BTHB 713.9BTHB 2,879.30 0.47% down 16% down Germany
3BiogenBIIB · Health CareTHB 619.5BTHB 1.26TTHB 8,509.30 0.34% down 49% up United States
4AmgenAMGN · Health CareTHB 293.8BTHB 8.4TTHB 15,537.56 0.95% down 34% up United States
5ModernaMRNA · Health CareTHB 293.5BTHB 2.84TTHB 7,016.72 3.93% down 755% up United States
6argenxARGX · Health CareTHB 248.5BTHB 2.02TTHB 32,149.35 0.36% down 4% up Belgium
7QiagenQGEN · Health CareTHB 128.2BTHB 348.6BTHB 1,688.02 0.12% down 12% up Netherlands
8Neurocrine BiosciencesNBIX · Health CareTHB 110.4BTHB 569.8BTHB 5,629.67 0.37% up 20% up United States
9VaxcytePCVX · Health CareTHB 91.1BTHB 319BTHB 2,015.44 3.59% down 22% up United States
10ExelixisEXEL · Health CareTHB 73.3BTHB 567.1BTHB 2,324.21 2.09% up 63% up United States
11Bio-TechneTECH · Health CareTHB 71.5BTHB 387.1BTHB 2,464.34 0.22% down 26% up United States
12RepligenRGEN · Health CareTHB 71.5BTHB 351.8BTHB 5,502.77 0.37% down 5% up United States
13CRISPR TherapeuticsCRSP · Health CareTHB 65.2BTHB 132.1BTHB 1,362.29 0.54% down 21% down Switzerland
14Revolution MedicinesRVMD · Health CareTHB 55.3BTHB 1.19TTHB 5,520.07 2.50% down 131% up United States
15Kymera TherapeuticsKYMR · Health CareTHB 53.6BTHB 352BTHB 4,123.17 3.44% down 87% up United States
16Krystal BiotechKRYS · Health CareTHB 41.4BTHB 300.2BTHB 10,129.80 0.22% up 46% up United States
17ImmunovantIMVT · Health CareTHB 28.9BTHB 233.2BTHB 1,126.82 0.21% down 43% up United States
18CG OncologyCGON · Health CareTHB 25.5BTHB 239.2BTHB 2,678.43 6.89% down 85% up United States
19Twist BioscienceTWST · Health CareTHB 16BTHB 259.1BTHB 3,800.16 6.63% up 340% up United States
20Scholar Rock HoldingSRRK · Health CareTHB 8.3BTHB 186.6BTHB 1,529.56 1.21% up 14% up United States
21Adaptive BiotechnologiesADPT · Health CareTHB 7.4BTHB 156.5BTHB 966.67 2.22% up 88% up United States
22Kodiak SciencesKOD · Health CareTHB 5.3BTHB 214.8BTHB 3,284.42 3.90% down 396% up United States
23Halozyme TherapeuticsHALO · Health CareTHB 1.7BTHB 371.2BTHB 3,256.26 0.55% down 37% up United States
24ImmunityBioIBRX · Health Care-THB 17BTHB 226BTHB 212.40 4.68% up 193% up United States

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Net assets is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 33.9300 THB).

Questions and answers

Which biotech rank first by net assets?

Gilead Sciences (THB 770.3B), BioNTech (THB 723.7B) and Biogen (THB 619.5B) are the top three of the 24 biotech ranked by net assets as of 18 Nov 2026, 13:49 UTC.

How many biotech are in this ranking?

24 are ranked by net assets.

What are these biotech worth together?

The 24 biotech ranked by net assets have a combined market value of THB 28.81T as of 18 Nov 2026, 13:49 UTC.

What does ranking by net assets measure?

Shareholders' equity at the end of the latest fiscal year: what the company owns less what it owes. A negative figure means it owes more than it owns.

Cite this page

Funkfolio, “Largest biotech by net assets”, data as of 18 November 2026. https://funkfolio.com/companies/category/biotech?by=net-assets

Underlying data: Yahoo Finance; SEC EDGAR.